Top Markets
Coin of the day
Molecure S.A. Molecure S.A.

Molecure S.A.

MOC
Rankning i aktier #26168
Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in... Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in the research, development, and commercialization of innovative therapies designed to combat neoplastic (cancer) and inflammatory conditions. The company's pipeline prominently features OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has successfully advanced through Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and sarcoidosis. Additionally, Molecure is progressing its YKL-40 program for cancer and fibrosis, OATD-02 for oncology applications, and a Deubiquitinase program. Established in 2012, this Warsaw-headquartered enterprise adopted the name Molecure S.A. in March 2022, having previously been known as OncoArendi Therapeutics S.A.
Aktiekurs
$1.73
Marknadsvärde
$42.88M
Förändring (1 dag)
2.16%
Förändring (1 år)
-18.85%
Land
PL
Handel Molecure S.A. (MOC)

Kategori

Aktiekurshistorik för Molecure S.A. (MOC)
Högsta slutkurs: $1.72 den 2026-08-01

Lägsta slutkurs: $8.01 den 2018-04-01
Aktiekurshistorik för Molecure S.A. från 2018 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -4.92%
2025 -23.76%
2024 -51.57%
2023 52.92%
2022 -63.44%
2021 -31.76%
2020 420.16%
2019 -41.51%
2018 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$539.78 36.87%
US
$1.04K 56.66%
NL
$120.74 -14.98%
AU
$761.87 7.04%
CH
$133.79 397.56%
US